Skip to main content
Clinical Trials/IRCT20200825048515N70
IRCT20200825048515N70
Recruiting
Phase 2

Comparative study of the therapeutic results of Carboplatin, Etoposide, ARAC, Melfalan chemotherapy regimes with CCNU, Etoposide, ARAC, Melfalan diet as a diet before autologous stem cell transplantation in patients with resistant / recurrent lymphoma

Esfahan University of Medical Sciences0 sites44 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Condition 1: Hodgkin lymphoma. Condition 2: Non Hodgkin lymphoma.
Sponsor
Esfahan University of Medical Sciences
Enrollment
44
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age above 18 years
  • Having Hodgkin/non\-Hodgkin of lymphoma resistant/relapsed
  • Consent to participate in the study

Exclusion Criteria

  • Patients who do not have suitable stem cells for transplantation during the initial stages of stem cell transplantation

Outcomes

Primary Outcomes

Not specified

Similar Trials